metabolic defects of vitamin B,2 or folic acid deficiency are likely to cause clinically significant lactic acidosis or hyperlactataemia.
The pathogenesis of megaloblastic anaemia is well understood and effective treatment is readily available. Despite this the mortality in severe cases (PCV < 0 25) is considerable,' and many patients die suddenly and unexpectedly. 2 The fall in plasma potassium after treatment has been suggested as a cause,' 3 and an additional or altermative factor might be the presence of an acidosis, particularly lactic acidosis, as suggested by the report of Coronato and Cohen.4 They described a patient with severe pernicious anaemia and lactic acidosis, although the concentration of blood lactate (5.2 mmol/l) does not fully explain the degree of acidosis (arterial pH 7 25; anion gap 31-5 mmol/l), and other anions may have been involved. Because of compensatory mechanisms anaemia has a minimal effect on blood lactate.5 In vitamin B2 deficiency, however, the metabolic defects might cause accumulation of lactate and methylmalonic acids and so contribute to an acidosis.
This study was carried out to assess the frequency of acidosis, including lactic acidosis, in patients with severe megaloblastic anaemia before and after treatment. Accepted for publication 3 February 1982 All surviving patients responded to specific haematinic therapy. Patient 10 was admitted in severe circulatory and renal failure, and was hyperglycaemic (plasma urea 30 mmol/l, blood glucose 20 mmol/l). She had a compensated metabolic acidosis with anion gap 26 mmol/l, bicarbonate 10 mmol/l, and arterial pH 7-49, Pco2 2-5 kPa, P02 11-2 kPa, giving a calculated non-respiratory pH of 7.24.10
Blood lactate was 11.8 mmol/l (NR = 0-3-2-3 mmol/l) and pyruvate 590 ,mol/l (NR = 57-107 mmol/l) with slightly raised lactate:pyruvate (L:P) ratio of 20 (NR = 5-15 mmol/l). Before death, and with treatment, these values had fallen to 3-6 mmol/l, 200 ,umoWl and 18 respectively. Accumulation of lactate seemed to be the principal cause of acidosis in this patient.
Patient 7 had normal lactate and pyruvate concentrations when first tested but these rose to sharp peaks of 10-3 mmol/l and 960 ,umol/l respectively on day 4. His plasma bicarbonate concentration fell slightly to 19 mmol/l at this time but the L:P ratio remained normal.
Five patients had mild hypokalaemia after treatment, and three were given potassium supplements. Patient 6 had mild chronic renal failure and marginally low plasma bicarbonate. All other patients had normal values for plasma sodium, chloride, urea and creatinine and all patients except number 10 had a normal anion gap throughout, with normal arterial blood pH on admission.
Discussion
Severe anaemia per se is unlikely to cause either lactic acidosis or more than minimal raised concentration of blood lactate5-7 and reported associations between anaemia and lactic acidosis have generally been observed in patients with coincident circulatory failure." An exception is Coronato and Cohen's patient (1969) ,4 who had pernicious anaemia and presented with a severe acidosis but little evidence of circulatory failure. The blood lactate concentrations do not fully account for the acidosis, however. The interesting possibility has been raised that there might be specific metabolic defects in B,2 deficiency which could cause such an acidosis.7 The results of this study do not support this hypothesis. Only one patient had hyperlactataemia before treatment and there was an obvious cause other than the megaloblastic anaemia-that is, shock and diabetes. No other patient had lactic acidosis or a significantly abnormal arterial blood pH.
The raised concentrations of lactate and pyruvate found in patient 7 also seem unlikely to be causally related to Vitamin B,2 deficiency or anaemia since treatment with hydroxocobalamin had been given for three days before the lactate concentration rose. 
